Published in Viral Immunol on January 01, 1987
Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog (2010) 3.89
Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36. Immunology (1989) 1.18
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner. MBio (2016) 0.94
Molecular basis for expression of the A48 regulatory idiotope on antibodies encoded by immunoglobulin variable-region genes from various families. Proc Natl Acad Sci U S A (1989) 0.90
Autoantibodies of various specificities encoded by genes from the VH J558 family bind to foreign antigens and share idiotopes of antibodies specific for self and foreign antigens. J Exp Med (1987) 0.89
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus. Proc Natl Acad Sci U S A (2016) 0.88
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact. Proc Natl Acad Sci U S A (2016) 0.82
Activation of clones producing self-reactive antibodies by foreign antigen and antiidiotype antibody carrying the internal image of the antigen. J Clin Invest (1989) 0.81
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol (1968) 5.69
The immunoglobulin heavy chain variable region (Igh-V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes. Eur J Immunol (1984) 5.33
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29
Changing respiratory pathways in potato tuber slices. Plant Physiol (1961) 4.84
Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci U S A (1969) 4.84
Differences in RNA patterns of influenza A viruses. J Virol (1976) 4.68
Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol (1968) 4.62
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science (1991) 4.53
Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells. J Virol (1977) 4.52
Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J Exp Med (1974) 4.48
The DCC protein and prognosis in colorectal cancer. N Engl J Med (1996) 3.51
Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes. Proc Natl Acad Sci U S A (1976) 3.19
Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science (1993) 3.03
Mapping of the influenza virus genome. III. Identification of genes coding for nucleoprotein, membrane protein, and nonstructural protein. J Virol (1976) 2.73
Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. J Immunol (1992) 2.68
Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis (1974) 2.66
Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation (2000) 2.44
Genetic control of antibody variable regions. Cold Spring Harb Symp Quant Biol (1977) 2.35
Active suppression of immunoglobulin allotype synthesis. II. Transfer of suppressing factor with spleen cells. J Exp Med (1972) 2.34
Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants. Virology (1983) 2.32
Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell (2001) 2.29
Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones. J Exp Med (1981) 2.28
Dynamics of intramural and transmural reentry during ventricular fibrillation in isolated swine ventricles. Circ Res (2001) 2.24
P1 and P3 proteins of influenza virus are required for complementary RNA synthesis. J Virol (1977) 2.19
Comparison of a hemagglutination treponemal test for syphilis (HATTS) with other serologic methods for the diagnosis of syphilis. Sex Transm Dis (1979) 2.14
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol (1999) 2.14
Rec8p, a meiotic recombination and sister chromatid cohesion phosphoprotein of the Rad21p family conserved from fission yeast to humans. Mol Cell Biol (1999) 2.09
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol (1996) 2.07
Postulates defining pathogenic autoantibodies and T cells. Autoimmunity (1991) 2.04
False-positive reactions in the rapid plasma reagin-card, fluorescent treponemal antibody-absorbed, and hemagglutination treponemal syphilis serology tests. J Clin Microbiol (1979) 2.01
Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. Nature (1975) 2.01
Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein. J Virol (1978) 1.99
Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science (1989) 1.96
Antigenic and genetic evolution of equine H3N8 influenza A viruses. J Gen Virol (1996) 1.96
The T suppressor cell alloantigen Tsud maps near immunoglobulin allotype genes and may be an heavy chain constant-region marker on a T cell receptor. J Exp Med (1981) 1.94
Biased expression of JH-proximal VH genes occurs in the newly generated repertoire of neonatal and adult mice. J Exp Med (1990) 1.91
Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis (1971) 1.90
Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J Virol (1992) 1.88
Lithographically patterned nanowire electrodeposition. Nat Mater (2006) 1.86
The induction of broadened (multitypic) immunity with doubly antigenic influenza virus recombinants. Trans Assoc Am Physicians (1965) 1.86
Epidemiology of an international outbreak of Salmonella agona. Lancet (1973) 1.76
Experimental transmission of influenza virus infection in mice. 3. Differing effects of immunity induced by infection and by inactivated influenza virus vaccine on transmission of infection. J Exp Med (1967) 1.68
Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol (1975) 1.68
The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol (1977) 1.64
Highlights of the Digital Imaging Network-Picture Archiving and Communications System Project. J Digit Imaging (1997) 1.64
Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol (1998) 1.61
The genetic basis of antibody production: the dominant anti-arsonate idiotype response of the strain A mouse. Eur J Immunol (1982) 1.60
Mapping of the influenza virus genome. II. Identification of the P1, P2, and P3 genes. Virology (1977) 1.60
Antigenic variants of influenza viruses: marked differences in the frequencies of variants selected with different monoclonal antibodies. Virology (1980) 1.59
Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. Ann Intern Med (1997) 1.58
Changes in children's behavior after hospitalization. Some dimensions of response and their correlates. Am J Dis Child (1966) 1.56
Protective role of gamma interferon during the recall response to influenza virus. J Virol (1998) 1.55
Nonrandom association of parental genes in influenza A virus recombinants. Virology (1979) 1.55
Selection and identification of influenza virus recombinants of defined genetic composition. J Virol (1976) 1.54
Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med (1997) 1.53
Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J Exp Med (1996) 1.51
Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA). Virology (1974) 1.50
Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities. J Clin Invest (1986) 1.48
Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene (1999) 1.47
Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol (2001) 1.46
Induction of antiphosphorylcholine antibody formation by anti-idiotypic antibodies. J Exp Med (1975) 1.45
Plague in San Diego. West J Med (1978) 1.45
Idiotype-anti-idiotype network. II. Activation of silent clones by treatment at birth with idiotypes is associated with the expansion of idiotype-specific helper T cells. J Exp Med (1982) 1.43
Idiotype vaccines: forgotten but not gone. Nat Med (1998) 1.42
Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J Infect Dis (1999) 1.41
Maternally transmitted target antigen for unrestricted killing by NZB T lymphocytes. J Exp Med (1980) 1.41
The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias. J Am Coll Cardiol (2000) 1.40
Activating transcription factor-1 can mediate Ca(2+)- and cAMP-inducible transcriptional activation. J Biol Chem (1993) 1.39
The use of an animal model to study transmission of influenza virus infection. Am J Public Health Nations Health (1968) 1.39
Pharmacologic strategies for treating gastroesophageal reflux disease. Clin Ther (2000) 1.38
Quantitative assessment of children's activity in and out of bed. Am J Dis Child (1967) 1.38
Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J Virol (1996) 1.37
Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. J Virol (1996) 1.34
Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS. J Exp Med (1976) 1.34
The antigenic relationship of the neuraminidase of Hong Kong virus to that of other human strains of influenza A virus. Bull World Health Organ (1969) 1.33
Difference in protein patterns of influenza A viruses. Virology (1977) 1.30
The detection of a population of submillimeter-bright, strongly lensed galaxies. Science (2010) 1.28
Adenovirus type 7b in a children's hospital. J Infect Dis (1983) 1.26
Experimental transmission of influenza virus infection in mice. IV. Relationship of transmissibility of different strains of virus and recovery of airborne virus in the environment of infector mice. J Exp Med (1967) 1.25
Nonlinkage of neurovirulence exclusively to viral hemagglutinin or neuraminidase in genetic recombinants of A-NWS (HON1) influenza virus. J Virol (1973) 1.25
Genetic composition of a high-yielding influenza A virus recombinant: a vaccine strain against "Swine" influenza. Science (1976) 1.24
Evidence that a single replication fork proceeds from early to late replicating domains in the IgH locus in a non-B cell line. Mol Cell (1999) 1.24
Shared idiotypes among monoclonal antibodies specific for different immunodominant sugars of lipopolysaccharide of different Gram-negative bacteria. Proc Natl Acad Sci U S A (1982) 1.24
Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice. J Exp Med (1988) 1.23
Atypical VH-D-JH rearrangements in newborn autoimmune MRL mice. J Immunol (1999) 1.22
Cellular immune responses of mice to influenza virus vaccines. J Immunol (1980) 1.21
The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur J Pharmacol (1993) 1.21
Nucleotide sequence comparison of the Adh gene in three drosophilids. J Mol Evol (1984) 1.18
Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA. Int Immunol (1993) 1.14
A mouse model for immunization with ex vivo virus-infected dendritic cells. Cell Immunol (2000) 1.14
Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience. J Immunol (1987) 1.13
Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proc Natl Acad Sci U S A (1995) 1.13